Distinct phenotypes of children with perianal perforating Crohn's disease

Scott S Short1, Marla C Dubinsky, Shervin Rabizadeh

  • 1Division of Pediatric Surgery, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Insights

Children with Crohn's disease (CD) who develop perianal perforating disease (PF) during therapy face a more severe condition. These patients are more likely to need surgery, such as diverting ileostomy or colectomy, compared to those diagnosed with PF at the outset.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Surgical Outcomes in Crohn's Disease

Background:

  • Perianal perforating disease (PF) affects approximately 15% of pediatric Crohn's disease (CD) patients.
  • The clinical course of pediatric CD with PF presenting at diagnosis versus developing during therapy is not well understood.

Purpose of the Study:

  • To compare the disease course and treatment outcomes of pediatric CD patients who present with perianal perforating disease (PF-CD0) at diagnosis versus those who develop PF during therapy (PF-CD1).

Main Methods:

  • A prospective, single-institution observational registry of pediatric CD patients was utilized.
  • Children diagnosed with perianal perforating CD (abscesses and/or fistulae) were identified.
  • Patients were categorized into PF-CD0 (present at diagnosis) and PF-CD1 (developed during therapy) groups for comparison.

Main Results:

  • Of 215 children with CD, 38 (18%) developed PF over a median follow-up of 4.5 years.
  • PF-CD0 patients (n=26) were more likely to be younger males.
  • PF-CD1 patients (n=12) showed a significantly higher likelihood of requiring diverting ileostomy (42% vs. 8%) and colectomy (33% vs. 4%).
  • Multivariable analysis indicated that PF-CD1 independently predicted an increased rate of diverting ileostomy (OR 19.1).

Conclusions:

  • Pediatric CD patients developing PF during therapy exhibit a more severe disease phenotype.
  • These patients have a substantially higher probability of requiring surgical interventions like diverting ileostomy or colectomy compared to those presenting with PF at diagnosis.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...